Substitutes of Prescription Medicines - A Review of Concerns Relevant to Doctors and Patients

Substitutes of Prescription Medicines - A Review of Concerns Relevant to Doctors and Patients

A very large part of India’s population fulfils its healthcare needs from government run healthcare delivery system which is free, contributory or highly subsidised. Use of medicines forms a large part of healthcare facility. As the number of medicines and brands are ever increasing in today’s mar...

Descripció completa

Dades bibliogràfiques
Autors principals:	Jayant Kumar Kairi, Ashok Kumar Sharma
Format:	Article
Idioma:	English
Publicat:	JCDR Research and Publications Private Limited 2017-08-01
Col·lecció:	Journal of Clinical and Diagnostic Research
Matèries:	brand names generic therapeutic
Accés en línia:	https://jcdr.net/articles/PDF/10439/28552_CE[Ra]_F(Sh)PF1_(SY_MJ_PY)_PFA(SY_SS).pdf

Ítems similars

Opinions of Czech general practitioners on generic drugs and substitution
per: Dosedel Martin, et al.
Publicat: (2014-12-01)

Is Brand Name Best? Brand name versus generic pharmaceuticals in clinical practice
per: Andrea Bakker
Publicat: (2017-06-01)

Prescription trends of doctors against cardiovascular system diseases
per: Mariam Devis, et al.
Publicat: (2020-01-01)

Knowledge and perceptions of medical students about generic medicines in a medical college in North India
per: Anita Kumari, et al.
Publicat: (2023-01-01)

Generic Medicine and Generic Prescribing in Nepal: An Implication for Policymakers
per: Shrestha R, et al.
Publicat: (2022-02-01)

Psychiatrists’ prescriptions
per: Poduri Gopala Sarma
Publicat: (2015-01-01)

Drug switching in the Netherlands: a cohort study of 20 active substances
per: Pieter J. Glerum, et al.
Publicat: (2020-07-01)

Generic substitution for prescribed brand medicines in Ethiopia: knowledge, attitude and practice among pharmacy professionals in community drug retail outlets
per: Sintayehu Alemu, et al.
Publicat: (2022-07-01)

Drug interchangeability: Clinical efficacy and safety
per: S. K. Zyryanov, et al.
Publicat: (2017-06-01)

Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumonia
per: Cheng-Yi Wang, et al.
Publicat: (2022-09-01)

North American cost analysis of brand name versus generic drugs for the treatment of glaucoma
per: Malvankar-Mehta MS, et al.
Publicat: (2019-12-01)

Evaluation of Clinical outcomes of Generic versus Reference Ivabradine in Heart Failure Patients
per: Hadeer Eid, et al.
Publicat: (2020-12-01)

Availability of different branded generic vildagliptin after off-patenting: An observation from India
per: Shambo S Samajdar, et al.
Publicat: (2023-01-01)

Prescription and use of “equivalent” drugs
per: Mario Eandi
Publicat: (2007-06-01)

Factors influencing the use of the “not for generic substitution” mention for prescriptions in primary care: a survey with general practitioners
per: Virgil Beauvais, et al.
Publicat: (2018-11-01)

Generic drugs in ophthalmic practice: Boon or bane?
per: Murali Ariga, et al.
Publicat: (2017-01-01)

A prescrição racional em medicina veterinária e os nomes dos fármacos dos medicamentos alopáticos Rational prescription in veterinary medicine and the names of active substances of alopatic medicines
per: Augusto Langeloh
Publicat: (1996-08-01)

A Verdade do Sujeito e sua Veiculação pelos Nomes
per: Oswaldo França Neto
Publicat: (2018-11-01)

Sexually transmitted diseases therapy. Rational choice
per: A A Khryanin
Publicat: (2015-08-01)

Brand relevance : making competitors irrelevant /
per: 368389 Aaker, David A.
Publicat: (c201)

Why Johnny cant brand : rediscovering the lost art of the big idea /
per: 290824 Schley, Bill, et al.
Publicat: (2005)

Are antibiotics substandard in Lebanon? Quantification of active pharmaceutical ingredients between brand and generics of selected antibiotics
per: Eva Hobeika, et al.
Publicat: (2020-02-01)

Good vs. Bad: An Empirical Analysis of the Brand Names of Coronavirus Vaccines
per: László Kovács
Publicat: (2024-02-01)

Brandsimple : how the best brands keep it simple and succeed /
per: 424641 Adamson, Allen P.
Publicat: (2006)

B2B brand management /
per: 301835 Kotler, Philip, et al.
Publicat: (2006)

Creating powerful brands : the strategic route to success in consumer, industrial and service markets /
per: 433145 De Chernatony, Leslie, et al.
Publicat: (1992)

Primal branding : create zealots for your brand, your company, and your future /
per: 268683 Hanlon, Patrick
Publicat: (2006)

Brain tattoos : creating unique brands that stick in your customers'minds /
per: 296340 Post, Karen
Publicat: (2005)

Passion branding : harnessing the power of emotion to build strong brands /
per: 262582 Duffy, Neill, et al.
Publicat: (2003)

The best of branding : best practices in corporate branding /
per: 390289 Gregory, James R.
Publicat: (2004)

Asian brand strategy : how Asia builds strong brands /
per: Roll, Martin, 1967-
Publicat: (2006)

Branding : a refrence guide to solving your toughest branding problems and strengthening your market position /
per: 203615 Van Auken, Brad
Publicat: (2007)

The infinite asset : managing brands to create new value /
per: 404043 Hill, Sam, et al.
Publicat: (c200)

Clarifications needed concerning the new Article 59 dealing with pleomorphic fungi
per: Walter Gams, et al.
Publicat: (2012-12-01)

HOW TO BRIDGE THE DISTANCE BETWEEN BUSINESS STRATEGY AND DESIGN : A WHITEBOARD OVERVIEW /
per: Neumeier, Marty, author
Publicat: (2003)

The brand bubble : the looming crisis in brand value and how to avoid it /
per: 322860 Gerzema, John, et al.
Publicat: (2008)

THE PROBLEMS ASSOCIATED WITH SWITCHING BRAND-NAME ANTIEPILEPTIC DRUGS TO GENERICS: A FOCUS ON TOPAMAX: A REVIEW OF LITERATURE AND A CASE REPORT
per: K. Yu. Mukhin, et al.
Publicat: (2016-08-01)

Kellogg on branding : the marketing faculty of the Kellogg School of Management /
per: Tybout, Alice M., et al.
Publicat: (2005)

Brand stretch : why 1 in 2 extensions fail and how to beat the odds : a brandgym workout /
per: Taylor, David, 1964-
Publicat: (2004)

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
per: Karan eThakkar, et al.
Publicat: (2013-09-01)